Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 5/2021

Inhalt (27 Artikel)

Review

Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

Elena María Brozos-Vázquez, Roberto Díaz-Peña, Jorge García-González, Luis León-Mateos, Patricia Mondelo-Macía, María Peña-Chilet, Rafael López-López

Original Article

Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer

Tao Dao, Martin G. Klatt, Tatyana Korontsvit, Sung Soo Mun, Sean Guzman, Marissa Mattar, Oliver Zivanovic, Chrisann K. Kyi, Nicholas D. Socci, Roisin E. O’Cearbhaill, David A. Scheinberg

Original Article

B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis

Huimin Lu, Yanchao Ma, Mingyuan Wang, Jin Shen, Hongya Wu, Juntao Li, Nan Gao, Yanzheng Gu, Xueguang Zhang, Guangbo Zhang, Tongguo Shi, Weichang Chen

Original Article

Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas

Farah Succaria, Pia Kvistborg, Julie E. Stein, Elizabeth L. Engle, Tracee L. McMiller, Lisa M. Rooper, Elizabeth Thompson, Alan E. Berger, Michiel van den Brekel, Charlotte L. Zuur, John Haanen, Suzanne L. Topalian, Janis M. Taube

Open Access Original Article

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy

Ayaka Hara, Ryo Koyama-Nasu, Mariko Takami, Takahide Toyoda, Takahiro Aoki, Fumie Ihara, Masayoshi Kobayashi, Seiichiro Hirono, Tomoo Matsutani, Toshinori Nakayama, Yasuo Iwadate, Shinichiro Motohashi

Original Article

SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2

Michael Mark, Patrizia Froesch, Eric Innocents Eboulet, Alfredo Addeo, Miklos Pless, Sacha I. Rothschild, Wolf-Dieter Janthur, Henning Burmeister, Alex Friedlaender, Martina Schneider, Yannis Metaxas, Markus Joerger, Luciano Wannesson, Michael Schwitter, Nathalie Baudoux, Susanne Weindler, Christine Biaggi-Rudolf, Martin Früh

Open Access Original Article

Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients

Wolfgang M. Thaiss, Sergios Gatidis, Tina Sartorius, Jürgen Machann, Andreas Peter, Thomas K. Eigentler, Konstantin Nikolaou, Bernd J. Pichler, Manfred Kneilling

Open Access Original Article

Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy

Mikołaj Piotr Zaborowski, Patrycja Stefens-Stawna, Krystyna Osztynowicz, Tomasz Piorunek, Halina Batura-Gabryel, Agnieszka Dyzmann-Sroka, Wojciech Kozubski, Ewa Nowak-Markwitz, Sławomir Michalak

Original Article

Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters

Lata Singh, Mithalesh Kumar Singh, Maria Cristina Kenney, Martine J. Jager, Moshahid Alam Rizvi, Rachna Meel, Neiwete Lomi, Sameer Bakhshi, Seema Sen, Seema Kashyap

Open Access Original Article

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

J. M. R. Van der Meer, R. J. A. Maas, K. Guldevall, K. Klarenaar, P. K. J. D. de Jonge, J. S. Hoogstad-van Evert, A. B. van der Waart, J. Cany, J. T. Safrit, J. H. Lee, E. Wagena, P. Friedl, B. Önfelt, L. F. Massuger, N. P. M. Schaap, J. H. Jansen, W. Hobo, H. Dolstra

Original Article

In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes

Maryam Moradi-Chaleshtori, Mojgan Bandehpour, Sara Soudi, Samira Mohammadi-Yeganeh, Seyed Mahmoud Hashemi

Correction

Correction to: In vitro and in vivo evaluation of anti‑tumoral effect of M1 phenotype induction in macrophages by miR‑130 and miR‑33 containing exosomes

Maryam Moradi-Chaleshtori, Mojgan Bandehpour, Sara Soudi, Samira Mohammadi-Yeganeh, Seyed Mahmoud Hashemi

Open Access Original Article

The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors

Anne Scheuerpflug, Fatima Ahmetlić, Vera Bauer, Tanja Riedel, Martin Röcken, Ralph Mocikat

Original Article

Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression

Chun-Chia Cheng, Hsin-Chi Lin, Ya-Wen Chiang, Jungshan Chang, Zong-Lin Sie, Bi-Ling Yang, Ken-Hong Lim, Cheng-Liang Peng, Ai-Sheng Ho, Yi-Fang Chang

Open Access Original Article

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers

Ji Won Woo, Yul Ri Chung, Milim Kim, Hye Yeon Choi, Soomin Ahn, So Yeon Park

Open Access Original Article

IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas

Arianna Di Napoli, Daniele Greco, Giorgia Scafetta, Francesca Ascenzi, Alessandro Gulino, Luigi Aurisicchio, Fabio Santanelli Di Pompeo, Adriana Bonifacino, Enrico Giarnieri, John Morgan, Rita Mancini, Marshall E. Kadin

Original Article

Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma

Yusuke Mochizuki, Hiroshi Tazawa, Koji Demiya, Miho Kure, Hiroya Kondo, Tadashi Komatsubara, Kazuhisa Sugiu, Joe Hasei, Aki Yoshida, Toshiyuki Kunisada, Yasuo Urata, Shunsuke Kagawa, Toshifumi Ozaki, Toshiyoshi Fujiwara

Open Access Original Article

The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

Ming-Fang Wu, Chih-An Lin, Tzu-Hang Yuan, Hsiang-Yuan Yeh, Sheng-Fang Su, Chin-Lin Guo, Gee-Chen Chang, Ker-Chau Li, Chao-Chi Ho, Huei-Wen Chen

Open Access Original Article

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells

Farsaneh Sadeghlar, Annabelle Vogt, Raphael U. Mohr, Robert Mahn, Katrin van Beekum, Miroslaw Kornek, Tobias J. Weismüller, Vittorio Branchi, Hanno Matthaei, Marieta Toma, I. G. H. Schmidt-Wolf, Jörg C. Kalff, Christian P. Strassburg, Maria A. González-Carmona

Original Article

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement

Phillip M. Kemp Bohan, Robert C. Chick, Annelies T. Hickerson, Lynn M. Messersmith, Grant M. Williams, Jessica L. Cindass, Jamie Lombardo, Ryan Collins, Robert O. Brady, Diane F. Hale, George E. Peoples, Timothy J. Vreeland, Guy T. Clifton

Open Access Research Report

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

M. Schuiveling, E. H. J. Tonk, R. J. Verheijden, K. P. M. Suijkerbuijk

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.